Maloney Clinical Research Inc is categorized under Health Care Management in Conshohocken, PA and active since 2008.
Maloney Clinical Research Inc was established in 2008, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Care Management business, which does work in the B2B market, and is classified as a Health Care Management, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Susan Maloney at the company’s single location by writing to 322 West 11th Avenue, Conshohocken, Pennsylvania PA 19428 or by phoning (610) 940-9425. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Maloney Clinical Research Inc |
| Contact Person: | Susan Maloney |
| Address: | 322 West 11th Avenue, Conshohocken, Pennsylvania 19428 |
| Phone Number: | (610) 940-9425 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Health Care Management |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Maloney Clinical Research Inc was started in 2008 to provide professional Health Care Management under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Susan Maloney for inquiries that concern Maloney Clinical Research Inc by calling the company number (610) 940-9425, as your correspondence is most welcome. Additionally, the physical location of the single location of Maloney Clinical Research Inc can be found at the coordinates 40.085092,-75.302741 as well as the street address 322 West 11th Avenue in Conshohocken, Pennsylvania 19428.
For its online presence, you may visit Maloney Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.